Although this experiment provided insights into the potential impact of the CMTM6-CD58 axis on tumor cell survival in vivo, further investigation is needed to understand how CMTM6 and CD58 expression on tumor cells modulates T cell activities. The gene discussed is CD58; the disease is neoplasm.